Predicting prostate-specific antigen recurrence established: Now, who will survive?

被引：9

作者：

D'Amico, AV ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 15期

关键词：

D O I：

10.1200/JCO.2002.20.15.3188

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3188 / 3190

页数：3

共 36 条

[1]

Bauer JJ, 1997, CANCER, V79, P952, DOI 10.1002/(SICI)1097-0142(19970301)79:5<952::AID-CNCR12>3.3.CO

[2]

2-I

[3] Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer [J].

D'Amico, AV ;

Whittington, R ;

Malkowicz, SB ;

Schultz, D ;

Fondurulia, J ;

Chen, MH ;

Tomaszewski, JE ;

Renshaw, AA ;

Wein, A ;

Richie, JP .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) :1164-1172

[4] The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer [J].

D'Amico, AV ;

Schultz, D ;

Silver, B ;

Henry, L ;

Hurwitz, M ;

Kaplan, I ;

Beard, CJ ;

Renshaw, AA .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (03) :679-684

[5] Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: The basis for an adjuvant therapy trial [J].

DAmico, AV ;

Whittington, R ;

Malkowicz, SB ;

Schultz, D ;

Tomaszewski, JE ;

Wein, A .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) :1465-1469

[6] Identification of intermediate-risk prostate cancer patients treated with radical radiotherapy suitable for neoadjuvant hormone studies [J].

Duchesne, GM ;

Bloomfield, D ;

Wall, P .

RADIOTHERAPY AND ONCOLOGY, 1996, 38 (01) :7-12

[7] International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy [J].

Graefen, M ;

Karakiewicz, PI ;

Cagiannos, I ;

Quinn, DI ;

Henshall, SM ;

Grygiel, JJ ;

Sutherland, RL ;

Stricker, PD ;

Klein, E ;

Kupelian, P ;

Skinner, DG ;

Lieskovsky, G ;

Bochner, B ;

Huland, H ;

Hammerer, PG ;

Haese, A ;

Erbersdobler, A ;

Eastham, JA ;

de Kernion, J ;

Cangiano, T ;

Schröder, FH ;

Wildhagen, MF ;

van der Kwast, TH ;

Scardino, PT ;

Kattan, MW .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3206-3212

[8]

Graefen M, 2002, J UROLOGY, V167, P231

[9] Early prostate-specific antigen relapse after radical retropubic prostatectomy: Prediction on the basis of preoperative and postoperative tumor characteristics [J].

Graefen, M ;

Noldus, J ;

Pichlmeier, U ;

Haese, A ;

Hammerer, P ;

Fernandez, S ;

Conrad, S ;

Henke, RP ;

Huland, E ;

Huland, H .

EUROPEAN UROLOGY, 1999, 36 (01) :21-30

[10] Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: Results from CaPSURE [J].

Grossfeld, GD ;

Latini, DM ;

Lubeck, DP ;

Broering, JM ;

Li, YP ;

Mehta, SS ;

Carroll, PR .

UROLOGY, 2002, 59 (04) :560-565

← 1 2 3 4 →